Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03911154 · ClinicalTrials.gov registry record · NA
Evaluation of SmartSleep Technology for Improving the Efficiency and Restorative Quality of Sleep in Healthy Adults
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT03911154: Completed NA study, sponsored by University of Pennsylvania.
NCT03911154 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 9 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03911154, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
This study aims to assess whether slow wave sleep enhancement using SmartSleep technology benefits daytime cognitive performance during periods of chronic sleep restriction.
Primary Outcome
The PVT is a simple reaction time test that requires participants to react, as quickly as possible, by pressing a response key as soon as a rolling number counter presented in a box in the center of the computer screen appears. The PVT is a validated and widely-used measure of vigilant attention that is sensitive to the effects of sleep loss. The primary outcome was the number of PVT lapses. The minimum number of PVT lapses is "0" and there is no maximum number of lapses, which are defined as re
Interventions
- DEVICE Philips SmartSleep Technology--Continuous Fixed Interval modality
- DEVICE Philips SmartSleep Technology--Block modality
- DEVICE Philips SmartSleep Technology--In-Phase Adjustable modality
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2019-04-29 |
| Est. Completion | 2021-06-30 |
| Phase | NA |
What the finished NCT03911154 record still lists
NCT03911154 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 3 interventions - of which Philips SmartSleep Technology--Continuous Fixed Interval modality is the first listed.
NCT03911154 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03911154 about?
NCT03911154 is a clinical study titled "Evaluation of SmartSleep Technology for Improving the Efficiency and Restorative Quality of Sleep in Healthy Adults". This study aims to assess whether slow wave sleep enhancement using SmartSleep technology benefits daytime cognitive performance during periods of chronic sleep restriction.
What is the current status of trial NCT03911154?
This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2019-04-29. Estimated completion is 2021-06-30.
What interventions are being tested in trial NCT03911154?
The interventions under investigation include: Philips SmartSleep Technology--Continuous Fixed Interval modality (DEVICE), Philips SmartSleep Technology--Block modality (DEVICE), Philips SmartSleep Technology--In-Phase Adjustable modality (DEVICE).
Who is sponsoring clinical trial NCT03911154?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03911154's enrollment target sits among peer trials
9 1975th of 2000 higher than 25 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI